Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
AstraZeneca
Jun 27, 2024, 14:17 |
Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 26, 2024, 15:22 |
Insight
Results from the NIAGARA Phase III trial
AztraZeneca released the results of the NIAGARA phase III trial, where INFINZI (durvalumab) showed EFS…
Jun 26, 2024, 08:30 |
Insight
IMFINZI (durvalumab) showed improved EFS and OS for MIBC in NIAGARA Phase III trial
First immunotherapy regimen before and after surgery to extend survival in bladder cancer Positive high-level results…
Jun 24, 2024, 12:01 |
Insight
Jean-Charles Soria: Two provocative manuscripts suggest the therapeutic potential of JAK inhibition with immunotherapy in cancer
Jean-Charles Soria shared a post on LinkedIn: "Two provocative manuscripts suggest the therapeutic potential of…
Jun 23, 2024, 13:08 |
Drugs
Capivasertib is now approved in EU for HR+/HER2- breast cancer
Paolo Tarantino shared a post on X: "Capivasertib is now approved in EU for the…
Jun 22, 2024, 04:45 |
Blog
Susan Galbraith: I am passionate about supporting the next generation of female leaders in STEM
Susan Galbraith, Executive Vice President in Oncology R&D at AstraZeneca, shared on LinkedIn: "It was…
Jun 21, 2024, 12:28 |
Insight
Paolo Tarantino: The CAPItello290 trial did not meet the dual primary endpoints
Paolo Tarantino shared on X/Twitter: "Press Release: the CAPItello290 trial of 1L paclitaxel +/- capivasertib in…
Jun 17, 2024, 20:08 |
Blog
John Longshore: Nothing unites the oncology world quite like ASCO
John Longshore, Driving scientific innovation in oncology diagnostics as the Head of Scientific Affairs for…
Jun 15, 2024, 05:25 |
Blog
Leora Horn: An update on our recent review published in Trends in Cancer
Leora Horn, Head of Clinical Development, Late Oncology at AstraZeneca, shared a post on LinkedIn: "Together…
Jun 12, 2024, 03:30 |
Blog
Rasha Aboelhassan: Solving debates for the treatment of stage III inoperable lung cancer is challenging
Rasha Aboelhassan shared on LinkedIn: "For decades, solving debates for the treatment of stage III…
9
10
11
12
13
All:
186
Posts:
101 - 110
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube